Symposium
New horizons for HCC treatment
Chairwoman: Dr. Irene Bargelini
- HCC management guidelines evolution - Dr. Irene Bargelini (Pisa, Italy)
- INSPIRE: INitiative on SuPerselectIve cTACE Results- Prof. Thierry de Baere (Villejuif, France)
- Immunotherapy and cTACE combination an effective solution? Dr. Rafael Duran (Lausanne, Switzerland)
From April 24th to 27th
Explore our solutions
Come and discover how to bring HCC to the next level with our Liverlink®, Axessio™ and line extension offers with our experts either:
- Onsite at Guerbet booth
- On the ECIO virtual platform here.
Since Charles Dotter performed the very first angioplasty in 1964, the practice of Interventional Radiology has evolved significantly.
Hear from your peers on the evolution of interventional radiology
Guerbet announces it will more than double its line of microcatheters and launch a new line of guidewires, resulting in a broad range of interventional imaging and embolization solutions available.
Axessio™ Guidewire is class III medical device intended for use by physicians to introduce percutaneous intravascular catheters. For complete information about precautions and optimal usage conditions for these medical devices, we recommend consulting the instructions for use supplied with each device or with your local Guerbet representative(s). This information is intended for use only in countries with appropriate regulatory authority market clearance. Notified Body: NSAI 0050. Manufacturer: Brivant Ltd. Distributed in the EU by Guerbet. Axessio™ is a registered trademark of Accurate Medical Therapeutics Ltd. Any performance specifications are believed to be reliable and are the sole responsibility of the legal manufacturer Brivant Ltd.
P22001226